These results are consistent with prior reports describing several FcγR-independent, infection-enhancing mAbs, all of which bound epitopes within the NTD [19, 20, 31], and further suggest that additional binding specificities associated with infection enhancement may encompass regions of S2. This evidence concerns the gene FCGR2A and infection.